Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jonathan Mertens"'
Autor:
Jonathan Mertens, Jonas Weyler, Eveline Dirinck, Luisa Vonghia, Wilhelmus J. Kwanten, Laura Mortelmans, Cedric Peleman, Shivani Chotkoe, Maarten Spinhoven, Floris Vanhevel, Luc F. Van Gaal, Benedicte Y. De Winter, Christophe E.M. De Block, Sven M. Francque
Publikováno v:
JHEP Reports, Vol 5, Iss 7, Pp 100753- (2023)
Background & Aims: The epidemiology of non-alcoholic fatty liver disease (NAFLD) in people with type 1 diabetes (T1D) is not yet elucidated. This study aimed to assess the diagnostic accuracy of non-invasive tests for NAFLD, to investigate the preval
Externí odkaz:
https://doaj.org/article/1e1215ad4ad1428687e67109a0adbf59
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue a
Externí odkaz:
https://doaj.org/article/309a074d7b7f4f34b4d8166ab91feff0
Autor:
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Autoimmune destruction of pancreatic β-cells results in the permanent loss of insulin production in type 1 diabetes (T1D). The daily necessity to inject exogenous insulin to treat hyperglycemia leads to a relative portal vein insulin deficiency and
Externí odkaz:
https://doaj.org/article/442444f3193e4133b5738de2d5899e1d
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have been reported as a novel worldwide epidemic, very often associated with obesity, metabolic syndrome, and type 2 diabetes. Both conditions have also been shown to
Externí odkaz:
https://doaj.org/article/f5bb042fdc0148c58e5d896afc85a70c
Autor:
Ian Kellar, Rodis Paparodis, Erkka Valo, Moritz Liebmann, Johan Røikjer, Abduzhappar Gaipov, Flemming Dela, Kamilla Miskowiak, Anna Syreeni, Morten Hasselstrøm Jensen, Judy Wright, Erika Parente, Sarah Alderson, Suganthiya S. Croosu, Jonathan Mertens, Mads Thomsen, Andreas Andersen, Marek Brabec, Carsten Dahl Mørch, Kari Kalliokoski, Bolette Hartmann, Ole Hejlesen, Matthew Gillum, Tine Hansen, Anna K Kirjavainen, Kirsi Laitinen, Hindrik Mulder, Julie Forman, Pirjo Nuutila, Gerrit Van Hall, Peter Rossing, Stefan Mutter, Rula Bany Bakar, Lærke Smidt Gasbjerg, LENA THORN
Publikováno v:
Diabetologia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2dcb608bb0a6dc8fed20ffc6303bb19
http://europepmc.org/articles/PMC8408311
http://europepmc.org/articles/PMC8408311
Autor:
JONATHAN MERTENS, HENNAH T. DE WINTER, HADI MAZLOM, FRIDA W. PEIFFER, EVELINE L. DIRINCK, NIELS BOCHANEN, LUC F. VAN GAAL, CHRISTOPHE DE BLOCK
Publikováno v:
Diabetes. 71
Introduction: the SUSTAIN trials have shown significant improvements in weight and HbA1c levels in people with type 2 diabetes, but the effect and safety of semaglutide in people with type 1 diabetes (T1D) has not been explored yet. Aims & Methods: I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aea3fff4befedabf131abd72e381872c
https://doi.org/10.2337/db22-751-p
https://doi.org/10.2337/db22-751-p
Autor:
JONATHAN MERTENS, RIE BRASPENNING, FLORIS VANHEVEL, MAARTEN SPINHOVEN, SVEN FRANCQUE, CHRISTOPHE DE BLOCK
Publikováno v:
Diabetes. 71
Background: NAFLD is strongly associated with type 2 diabetes. Insulin resistance is proposed as a major contributor. NAFLD is increasingly reported in type 1 diabetes (T1D) , but whether insulin resistance is linked to NAFLD in this population needs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eeb7183bcfbb966172407ff7c387d39
https://doi.org/10.2337/db22-1340-p
https://doi.org/10.2337/db22-1340-p
Autor:
Jonathan Mertens, Maarten Spinhoven, Eveline Dirinck, Luisa Vonghia, Sven Francque, Block Christophe De
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8acdf5f984202de1fcc026341f2b8444
https://doi.org/10.1530/endoabs.81.rc10.1
https://doi.org/10.1530/endoabs.81.rc10.1
Autor:
Jessica Harding, Maria Paula Macedo, Bishal Gyawali, Andreas Kjaer, Daniel Esteban Coral Candelo, Morten Hasselstrøm Jensen, Sonya Deschênes, Aase Handberg, Alexander Y. Mayorov, Jens Juul Holst, Jonathan Mertens, Fleur Levrat-Guillen, Paola Parra Ramírez, Bolette Hartmann, Jon Mabley, Jayakumar Vadakekolathu, Ole Hejlesen, Soulef Maandi, Frank Otto, ANTHONY PIRON, Anna Zheleznyakova, Elaine Cowan, Khrystyna Moskva, Turkuler Ozgumus, Marija Petkovic
Publikováno v:
Diabetologia. 63:1-485
Background and aims: We have previously shown that interrupting prolonged periods of sitting with short, frequent light-intensity walking activity improves postprandial glucose levels in people with and at risk of Type 2 Diabetes. However, no researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e0162a265eb8c947788fe7cc31aed0a
https://doi.org/10.1007/s00125-020-05221-5
https://doi.org/10.1007/s00125-020-05221-5
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Therapeutic advances in endocrinology and metabolism
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Therapeutic advances in endocrinology and metabolism
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35347c464b5a9db0b3370bc7689e0647
http://europepmc.org/articles/PMC8613893
http://europepmc.org/articles/PMC8613893